Update in the CNS response to hypoglycemia

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 1, 2012, Pages 1-8

  McCrimmon, Rory J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; CYCLIC AMP; GLUCAGON; GLUCOKINASE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; NORADRENALIN; SEROTONIN;

AWARENESS; BRAIN METABOLISM; BRAIN STEM; CENTRAL NERVOUS SYSTEM; CEREBELLUM; CINGULATE GYRUS; COGNITION; GLUCOSE HOMEOSTASIS; HUMAN; HYPOGLYCEMIA; HYPOTHALAMUS; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; NEUROIMAGING; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PUTAMEN; REVIEW; RHOMBENCEPHALON; SENSOR; UNCUS;

ADAPTATION, BIOLOGICAL; ANIMALS; BLOOD GLUCOSE; CENTRAL NERVOUS SYSTEM; FEEDBACK, PHYSIOLOGICAL; HUMANS; HYPOGLYCEMIA; MODELS, BIOLOGICAL; NEUROENDOCRINE CELLS; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 84855520272     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1927     Document Type: Review

References (36)

1. McCrimmon R 2009 Glucose sensing during hypoglycemia: lessons from the lab. Diabetes Care 32:1357-1363
2. Amiel SA 2009 Hypoglycemia: from the laboratory to the clinic. Diabetes Care 32:1364-1371
3. Watts AG, Donovan CM 2010 Sweet talk in the brain: glucosensing, neural networks, and hypoglycemic counterregulation. Front Neuroendocrinol 31:32-43
4. Chan O, Cheng H, Herzog R, Czyzyk D, Zhu W, Wang A, Mc- Crimmon RJ, Seashore MR, Sherwin RS 2008 Increased GABAergic tone in the ventromedial hypothalamus contributes to suppression of counterregulatory responses after antecedent hypoglycemia. Diabetes 57:1363-1370
5. Gerich JE, Langlois M, Noacco C, Karam JH, Forsham PH 1973 Lack of glucagon response to hypoglycemia in diabetes: evidence for an intrinsic pancreatic α-cell defect. Science 182:171-173
6. Segel SA, Paramore DS, Cryer PE 2002 Hypoglycemia-associated autonomic failure in advanced type 2 diabetes. Diabetes 51:724-733 (Pubitemid 34760182)
7. Cryer P 2001 The prevention and correction of hypoglycemia. In: Jefferson LS, Cherrington AD, Goodman HM, eds. Handbook of physiology: a critical, comprehensive presentation of physiological knowledge and concepts. Sect. 7. The endocrine system. New York: Oxford University Press: 1057-1092
8. McCrimmon RJ, Sherwin RS 2010 Hypoglycemia in type 1 diabetes. Diabetes 59:2333-2339
9. Heller SR, Cryer PE 1991 Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after one episode of hypoglycemia in nondiabetic humans. Diabetes 40:223-226
10. Amiel SA, Sherwin RS, Simonson DC, Tamborlane WV 1988 Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes 37:901-907 (Pubitemid 19043718)
11. Davis SN, Mann S, Briscoe VJ, Ertl AC, Tate DB 2009 Effects of intensive therapy and antecedent hypoglycemia on counterregulatory responses to hypoglycemia in type 2 diabetes. Diabetes 58:701-709
12. 1997 Hypoglycemia in the Diabetes Control and Complications Trial. The Diabetes Control and Complications Trial Research Group. Diabetes 46:271-286
13. Gerstein HC, Miller ME, Byington RP, Goff Jr DC, Bigger JT, Buse JB, Cushman WC, Genuth S, Ismail-Beigi F, Grimm Jr RH, Probstfield JL, Simons-Morton DG, Friedewald WT 2008 Effects of intensive glucose lowering in type 2 diabetes.NEngl JMed358:2545-2559 (Pubitemid 351831356)
14. Fanelli CG, Epifano L, Rambotti AM, Pampanelli S, Di Vincenzo A, Modarelli F, Lepore M, Annibale B, Ciofetta M, Bottini P 1993 Meticulous prevention of hypoglycemia normalizes the glycemic thresholds and magnitude of most of neuroendocrine responses to, symptoms of, and cognitive function during hypoglycemia in intensively treated patients with short-term IDDM. Diabetes 42:1683-1689 (Pubitemid 23318128)
15. Cryer PE 1994 Banting lecture. Hypoglycemia: the limiting factor in the management of IDDM. Diabetes 43:1378-1389
16. Page KA, Williamson A, Yu N, McNay EC, Dzuira J, McCrimmon RJ, Sherwin RS 2009 Medium-chain fatty acids improve cognitive function in intensively treated type 1 diabetic patients and support in vitro synaptic transmission during acute hypoglycemia. Diabetes 58:1237-1244
17. Musen G, Simonson DC, Bolo NR, Driscoll A, Weinger K, Raji A, Théberge J, Renshaw PF, Jacobson AM 2008 Regional brain activation during hypoglycemia in type 1 diabetes. J Clin Endocrinol Metab 93:1450-1457 (Pubitemid 351519747)
18. Teh MM, Dunn JT, Choudhary P, Samarasinghe Y, Macdonald I, O'Doherty M, Marsden P, Reed LJ, Amiel SA 2010 Evolution and resolution of human brain perfusion responses to the stress of induced hypoglycemia. Neuroimage 53:584-592
19. MacLeod KM, Gold AE, Ebmeier KP, Hepburn DA, Deary IJ, Goodwin GM, Frier BM 1996 The effects of acute hypoglycemia on relative cerebral blood flow distribution in patients with type I (insulin-dependent) diabetes and impaired hypoglycemia awareness. Metabolism 45: 974-980 (Pubitemid 26282550)
20. Teves D, Videen TO, Cryer PE, Powers WJ 2004 Activation of human medial prefrontal cortex during autonomic responses to hypoglycemia. Proc Natl Acad Sci USA 101:6217-6221 (Pubitemid 38520554)
21. Henry PG, Criego AB, Kumar A, Seaquist ER 2010 Measurement of cerebral oxidative glucose consumption in patients with type 1 diabetes mellitus and hypoglycemia unawareness using (13)C nuclear magnetic resonance spectroscopy. Metabolism 59:100-106
22. Criego AB, Tkac I, Kumar A, Thomas W, Gruetter R, Seaquist ER 2005 Brain glucose concentrations in patients with type 1 diabetes and hypoglycemia unawareness. J Neurosci Res 79:42-47 (Pubitemid 40116416)
23. Segel SA, Fanelli CG, Dence CS, Markham J, Videen TO, Paramore DS, Powers WJ, Cryer PE 2001 Blood-to-brain glucose transport, cerebral glucose metabolism, and cerebral blood flow are not increased after hypoglycemia. Diabetes 50:1911-1917 (Pubitemid 33641613)
24. Oz G, Kumar A, Rao JP, Kodl CT, Chow L, Eberly LE, Seaquist ER 2009 Human brain glycogen metabolism during and after hypoglycemia. Diabetes 58:1978-1985
25. Mason GF, Petersen KF, Lebon V, Rothman DL, Shulman GI 2006 Increased brain monocarboxylic acid transport and utilization in type 1 diabetes. Diabetes 55:929-934 (Pubitemid 44100166)
26. Pan JW, Rothman TL, Behar KL, Stein DT, Hetherington HP 2000 Human brain β-hydroxybutyrate and lactate increase in fastinginduced ketosis. J Cereb Blood Flow Metab 20:1502-1507
27. Jacobson AM, Musen G, Ryan CM, Silvers N, Cleary P, Waberski B, Burwood A, Weinger K, Bayless M, Dahms W, Harth J 2007 Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 356:1842-1852 (Pubitemid 46698465)
28. Frier BM 2011 Cognitive functioning in type 1 diabetes: the Diabetes Control and Complications Trial (DCCT) revisited. Diabetologia 54:233-236
29. Sämann A, Mühlhauser I, Bender R, Kloos Ch, Müller UA 2005 Glycaemic control and severe hypoglycaemia following training in flexible, intensive insulin therapy to enable dietary freedom in people with type 1 diabetes: a prospective implementation study. Diabetologia 48:1965-1970 (Pubitemid 41416904)
30. 2002 Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. BMJ 325:746
31. Monami M, Marchionni N, Mannucci E 2009 Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis. Diabetes Obes Metab 11:372-378
32. Cummins E, Royle P, Snaith A, Greene A, Robertson L, McIntyre L, Waugh N Clinical effectiveness and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes: systematic review and economic evaluation. Health Technol Assess 14:iii-iv, xi-xvi, 1-181
33. Beck RW, Hirsch IB, Laffel L, Tamborlane WV, Bode BW, Buckingham B, Chase P, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Huang ES, Kollman C, Kowalski AJ, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer SA, Wilson DM, Wolpert H, Wysocki T, Xing D 2009 The effect of continuous glucose monitoring in well-controlled type 1 diabetes. Diabetes Care 32:1378-1383
34. Ly TT, Hewitt J, Davey RJ, Lim EM, Davis EA, Jones TW 2011 Improving epinephrine responses in hypoglycemia unawareness with real-time continuous glucose monitoring in adolescents with type 1 diabetes. Diabetes Care 34:50-52
35. Buckingham B, Chase HP, Dassau E, Cobry E, Clinton P, Gage V, Caswell K, Willkinson J, Cameron F, Lee H, Bequette BW, Doyle 3rd FJ 2010 Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Care 33: 1013-1017
36. Leu J, Cui MH, Shamoon H, Gabriely I 2009 Hypoglycemia-associated autonomic failure is prevented by opioid receptor blockade. J Clin Endocrinol Metab 94:3372-3380